Search Results - "Cromer MK"

CRISPR–CAS9 mediated beta-cell regeneration: a transformative step in diabetes management.

Authors: Hujjat, Syeda Fadak Zahra Zahra, Syeda Hasnat

Source: Egyptian Journal of Medical Human Genetics. 6/22/2026, Vol. 27 Issue 1, p1-4. 4p.

Efficient encapsulation of CRISPR-Cas9 RNP in bioreducible nanogels and release in a cytosol-mimicking environment.

Authors: Westarp, Peter Keller, Thorsten Brand, Jessica et al.

Source: Discover Nano; 7/26/2025, Vol. 20 Issue 1, p1-21, 21p

Omics-aided design genome editing strategy for challenging human immortalized cell models.

Authors: Mendoza-Garcia, Patricia Keith, Benjamin Nordberg, Markus et al.

Source: PLoS ONE. 2/12/2026, Vol. 21 Issue 2, p1-15. 15p.

In utero lipid nanoparticle delivery achieves robust editing in hematopoietic stem cells.

Authors: Worthington AK Borges B Lum T et al.

Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 May 12. Date of Electronic Publication: 2025 May 12.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Miniaturized scalable arrayed CRISPR screening in primary cells enables discovery at the single donor resolution.

Authors: Patel, Miti A. Boribong, Brittany P. Sinha, Hugo et al.

Source: Scientific Reports. 8/11/2025, Vol. 15 Issue 1, p1-15. 15p.

Applications of genome editing technologies in the treatment of human diseases.

Authors: Alshorman J Mehran MJ Miyanda Tembo K et al.

Source: Gene therapy [Gene Ther] 2026 Jun 15. Date of Electronic Publication: 2026 Jun 15.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5462 (Electronic) Linking ISSN: 09697128 NLM ISO Abbreviation: Gene Ther Subsets: MEDLINE

Engineering Cas9: next generation of genomic editors.

Authors: Kovalev, Maxim A. Davletshin, Artem I. Karpov, Dmitry S.

Source: Applied Microbiology & Biotechnology; 2/14/2024, Vol. 108 Issue 1, p1-19, 19p

This result is not displayed to guests.
Login for full access.

Enhancement of erythropoietic output by Cas9-mediated insertion of a natural variant in haematopoietic stem and progenitor cells.

Authors: Luna SE Camarena J Hampton JP et al.

Source: Nature biomedical engineering [Nat Biomed Eng] 2024 Dec; Vol. 8 (12), pp. 1540-1552. Date of Electronic Publication: 2024 Jun 17.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101696896 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2157-846X (Electronic) Linking ISSN: 2157846X NLM ISO Abbreviation: Nat Biomed Eng Subsets: MEDLINE

DNA and RNA editing for the therapy of human diseases: current status, challenges, and future prospects.

Authors: Zhao R Wang C Li J et al.

Source: Molecular biomedicine [Mol Biomed] 2026 Apr 22; Vol. 7 (1). Date of Electronic Publication: 2026 Apr 22.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Singapore Country of Publication: Singapore NLM ID: 9918283581406676 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-8651 (Electronic) Linking ISSN: 26628651 NLM ISO Abbreviation: Mol Biomed Subsets: MEDLINE

Artificial Intelligence-Assisted CRISPR Gene Editing: Current Advances, Clinical Challenges, and Future Directions in Precision Medicine.

Authors: Yousefian, Mahdi Baharmast, Maryam

Source: Avicenna Journal of Medical Biotechnology. Jan-Mar2026, Vol. 18 Issue 1, p3-15. 13p.

A bioinformatic analysis of gene editing off-target loci altered by common polymorphisms, using 'PopOff'.

Authors: Samson, Christopher du Rand, Alex Hunt, John et al.

Source: Journal of the Royal Society of New Zealand. Dec2025, Vol. 55 Issue 6, p2440-2463. 24p.

Enhanced fetal hemoglobin production via dual-beneficial mutation editing of the HBG promoter in hematopoietic stem and progenitor cells for β-hemoglobinopathies.

Authors: Chandraprabha, Prathibha Babu Azhagiri, Manoj Kumar K. Venkatesan, Vigneshwaran et al.

Source: Stem Cell Research & Therapy. 12/31/2024, Vol. 15 Issue 1, p1-19. 19p.

Enhanced interaction between genome-edited mesenchymal stem cells and platelets improves wound healing in mice.

Authors: Li, De-Yong Li, Yu-Meng Lv, Dan-Yi et al.

Source: Journal of Tissue Engineering. 9/23/2024, p1-19. 19p.

Preventing secondary primary malignancies (SPMs) in CAR-T cell therapy through site-specific transgene integration into genomic safe harbors (GSHs).

Authors: Safarzadeh Kozani, Pooria Safarzadeh Kozani, Pouya

Source: Journal of Translational Medicine. 10/21/2025, Vol. 23 Issue 1, p1-18. 18p.

CRISPR/Cas9 in colorectal cancer: Revolutionizing precision oncology through genome editing and targeted therapeutics.

Authors: Alhasso, Bahjat Shareef, Abdulkareem Baldaniya, Lalji et al.

Source: Iranian Journal of Basic Medical Sciences. Oct2025, Vol. 28 Issue 10, p1279-1300. 22p.

Gene editing strategies to address current challenges in stem cell-derived β cell therapy for type 1 Diabetes.

Authors: Han, Jongsoo Lim, Donghyun Yang, Kisuk

Source: Journal of Tissue Engineering. 9/16/2025, Vol. 16, p1-18. 18p.

Sequential factor delivery enables efficient workflow for universal gene editing in clinical grade iPS cells.

Authors: Berger, Thomas Borisova, Elitsa Gamerschlag, Anna et al.

Source: Scientific Reports. 9/12/2025, Vol. 14 Issue 1, p1-12. 12p.

KMT2A and chronic inflammation as potential drivers of sporadic parathyroid adenoma.

Authors: Xu, Qin La, Ting Ye, Kaihong et al.

Source: Clinical & Translational Medicine. Jun2024, Vol. 14 Issue 6, p1-25. 25p.

Points to consider in the development of national human genome editing policy.

Authors: Nicol, Dianne Niemeyer, Simon Paxton, Rebecca et al.

Source: Cambridge Prisms: Precision Medicine. 2023, Vol. 1, p1-11. 11p.